Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 15/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | PLD2 | O14939 | 1/20 | 0.48 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6802711 | 0.90 | CALCRL (0.63) | CALCRLCYP3A4ALDH1A1OPRM1RAMP1 | |
| SCHEMBL6808345 | 0.89 | CALCRL (0.63) | CALCRLCYP3A4ALDH1A1OPRM1RAMP1 | |
| SCHEMBL6808589 | 0.84 | CALCRL (0.52) | CALCRLCYP3A4ALDH1A1RAMP1DRD2 | |
| SCHEMBL6807923 | 0.77 | CTSB (0.48) | CALCRLALDH1A1PLD2PLD1 | |
| SCHEMBL4698559 | 0.76 | CALCRL (0.65) | CALCRLCYP3A4ALDH1A1OPRM1RAMP1 | |
| SCHEMBL4698557 | 0.76 | CALCRL (0.65) | CALCRLCYP3A4ALDH1A1OPRM1RAMP1 | |
| SCHEMBL3963833 | 0.76 | CALCRL (0.81) | CALCRLCYP3A4ALDH1A1RAMP1 | |
| SCHEMBL6807110 | 0.74 | ITGA4 (0.47) | ALDH1A1 | |
| SCHEMBL6812351 | 0.74 | CALCRL (0.52) | CALCRLCYP3A4ALDH1A1RAMP1 | |
| SCHEMBL22869715 | 0.74 | HSD11B1 (0.73) | ALDH1A1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040039040-A1 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | TORAY INDUSTRIES, INC. (JP) | 2004-02-26 | — | — | US | disclosed |
| EP-1323709-A1 | UREA DERIVATIVE AND ADHESIVE-MOLECULE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT | TORAY INDUSTRIES, INC. (JP) | 2003-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039040-A1 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | ICAM1, VCAM1, EPCAM | CALCRL 1811/4885CYP3A4 3783/4885ALDH1A1 283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.